Francisco, Angeli .

HRN: 23-03-78  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
CO-AMOXICLAV 625MG (TAB)
05/27/2023
06/02/2023
PO
625mg
BID
Post Episiorhaphy
Waiting Final Action 
06/03/2023
LEVOFLOXACIN 500MG (TAB)
06/03/2023
06/10/2023
PO
500mg
OD
Wound Dehiscence
Waiting Final Action 
06/04/2023
METRONIDAZOLE 500MG (TAB)
06/04/2023
06/11/2023
PO
500 Mg
Every 8 Hours
S/P Episiorrhaphy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: